Synerkine Pharma
Synerkine Pharma B.V. focuses on development of novel fusion proteins, called Synerkines, that combine the immunoregulatory activity of different cytokines. These fusion proteins have unique benefits over the individual cytokines and modulate a broad number of targets, including key elements in the pain pathway. This provides treatment options for chronic pain conditions with a clearly differentiated mechanism of action over current analgesic drugs and holds tremendous therapeutic and commercial potential. Synerkine Pharma B.V. was founded in 2018 as a spin-off of the University Medical Center Utrecht (UMCU), the Netherlands.
7-day free trial · no credit card
Verified contacts
2
available on Kipplo
LinkedIn employees
8
1 to 10 range
Open roles
—
no listings
Distinct roles
2
indexed titles
Tech stack
1
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 2 verified contacts at Synerkine Pharma
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
2 contacts with verified email or phone · masked until revealed.
- SK
Stephen K. Long
Senior Advisor · Research & Development
EmailPhone - TD
Theo Dinklo
Vice President Research and Development · Research & Development
EmailPhone
Showing 2 of 2 verified contacts
Top roles at Synerkine Pharma
2 distinct titles indexed · top 2 shown.
- 1senior advisor
- 1vice president research and development
Sign up to unlock all 2 contacts at Synerkine Pharma
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 2 verified contacts at Synerkine Pharma
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.